As of now, the Red Sox are confident that Chris Sale doesn't need any sort of procedure for his ailing shoulder. Sale was diagnosed with mild inflammation in his left shoulder in late July and pitched sparingly over the final two months before pitching in the postseason.
The Red Sox exercised their 2019 option on Sale Tuesday for $15 million, the first indication that the Sox weren't overly concerned with his condition going forward.
"We anticipate him coming to spring training and be 100 percent,'' said Dave Dombrowski, "at this point, without any surgical procedures. We think just rest will take care of it. That's really where we are. But we don't anticipate any kind of surgical procedures whatsoever.''
____________________
___________________
____________________
__________________
______________